Record #46605

Lixisenatide protects doxorubicin-induced renal fibrosis by activating wNF-κB/TNF-α and TGF-β/Smad pathways

Notes from Retraction Watch

see also: https://pubpeer.com/publications/983F02C9C18817139AE18497C359FA

Citation lifecycle

How this paper is being cited

Pre-retraction
4
Same day
0
Post-retraction
1
% post-retraction
20.0%
~1.0 citations/yr before retraction · ~0.3 citations/yr after
citing papers

Who is still citing this work

Loading…